Faropenem
It is an oral penem/beta-lactam antibiotic with antibacterial activity against both aerobic and anerobic gram positive and gram-negative bacteria.Administered orally. Lower respiratory tract infections, ENT infections, and genito-urinary infections : 200mg tid can be increased to 300mg tid. Upper respiratory tract infections, skin and skin structure infections, and gynaecological infections : 150mg tid can be increased to 200mg tid.
PO Resp tract infections; Uncomplicated skin and skin structure infections As faropenem medoxomil: 300 mg bid for 7-10 days.
Hypersensitivity to Faropenem and other bata-lactams.
Stop the medicine if diarrhoea and loose bowel movement occur. Patient with family history of atopy. Pregnancy : Safety has not been established. Lactation : Use with caution. Padiatrics:Safety in infant has not been established. Geriatrics : Start with a dose of 150mg
Diarrhoea,abdominal pain, loose bowel movement, nausea, and rash are the most frequent adverse effects.
Imipenem, cilastatin, furosemide, sodium valporate
Brand Name | Manufactured by |
---|---|
Farofaith CV | Unifaith Biotech (P) Limited. |
Farofaith CV | Unifaith Biotech (P) Limited. |